Literature DB >> 10337358

Pharmacological control of rate and maintenance of sinus rhythm.

M D Ezekowitz1, R Lampert.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10337358     DOI: 10.1023/a:1008823202712

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  46 in total

1.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.

Authors:  M A Allessie; F I Bonke; F J Schopman
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.

Authors:  R H Falk; A Pollak; S N Singh; T Friedrich
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

3.  Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome.

Authors:  L B Mitchell; D G Wyse; H J Duff
Journal:  Circulation       Date:  1987-10       Impact factor: 29.690

4.  Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

Authors:  S Juul-Möller; N Edvardsson; N Rehnqvist-Ahlberg
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

5.  Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone.

Authors:  D L Disch; M L Greenberg; P T Holzberger; D J Malenka; J D Birkmeyer
Journal:  Ann Intern Med       Date:  1994-03-15       Impact factor: 25.391

6.  A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.

Authors: 
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

7.  Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction.

Authors:  D L Packer; G H Bardy; S J Worley; M S Smith; F R Cobb; R E Coleman; J J Gallagher; L D German
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

8.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

9.  Disopyramide-induced Torsade de Pointes.

Authors:  D Tzivoni; A Keren; S Stern; S Gottlieb
Journal:  Arch Intern Med       Date:  1981-06

10.  Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group.

Authors:  D M Salerno; V C Dias; R E Kleiger; V H Tschida; R J Sung; M Sami; L V Giorgi
Journal:  Am J Cardiol       Date:  1989-05-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.